Clinical Trials Directory

Trials / Unknown

UnknownNCT06190743

Perception of Cardiovascular Risk

Perception of Cardiovascular Risk: Description of the Phenomenon in Primary Prevention

Status
Unknown
Phase
Study type
Observational
Enrollment
271 (actual)
Sponsor
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers

Summary

The aim of the study is to describe the association between the perception of cardiovascular (CV) risk and the actual CV risk and, secondarily, to detect the actual CV risk to assess the prevalence of clinical risk factors, determined by means of appropriate instruments.

Detailed description

Cardiovascular (CV) disease is the major cause of premature death in adults that carries serious economic consequences. Risk perception for CV disease has been reported as the subjective judgment of the likelihood of having a CV event. Risk perception is an important precursor to adopting a healthy lifestyle. However, both overestimation and underestimation of actual risk due mostly to poor health literacy are common. For these reasons, CV prevention services of health care professionals (e.g., nurses, physicians) should, on the one hand, include screening for the presence of risk factors, and on the other hand, know the CV risk perceptions of those being cared for. The aim of the study is to describe the association between the perception of cardiovascular (CV) risk, investigated by means of the Perception of Risk of Heart Disease Scale and a Likert-5 scale question, and the actual CV risk according to the SCORE2 and, secondarily, to detect the actual CV risk ascertained by the SCORE2 and to assess the prevalence of clinical risk factors (alterations in the lipid, glucose, or anthropometric profile) determined by means of appropriate instruments.

Conditions

Interventions

TypeNameDescription
OTHERPrevention events organized by participating centersCardiovascular disease primary prevention events organized by centers participating in the study where capillary sampling will be performed on subjects to quantify plasma levels of cardiovascular risk factors and validated questionnaires will be administered

Timeline

Start date
2023-09-29
Primary completion
2023-10-27
Completion
2024-09-01
First posted
2024-01-05
Last updated
2024-01-05

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06190743. Inclusion in this directory is not an endorsement.